Azurity   Report issue

Founded: Wilmington MA United States (2000)
Status: No NME R&D (2000)

Organization Overview

First Clinical Trial
None
First Marketed Drug
2000
erythromycin (ilosone)
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

AZURITY